105 related articles for article (PubMed ID: 33197619)
1. A study of multinucleated giant cells in esophageal cancer.
Wang H; Zhou J; Li J; Geng Y; Meng P; Ma C; Zhu Z; Zhang W; Hong L; Quan Y; Wei J; Huang Q; Zhou Y; Su Z; Zhu X; Chen C; Chen S; Gu J
Clin Immunol; 2021 Jan; 222():108600. PubMed ID: 33197619
[TBL] [Abstract][Full Text] [Related]
2. Multinucleated giant cell reaction in lower lip squamous cell carcinoma: a clinical, morphological, and immunohistochemical study.
Santos HBP; Miguel MCDC; Pinto LP; Gordón-Núñez MA; Alves PM; Nonaka CFW
J Oral Pathol Med; 2017 Oct; 46(9):773-779. PubMed ID: 28199754
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma.
Zhang Y; Ren H; Wang L; Ning Z; Zhuang Y; Gan J; Chen S; Zhou D; Zhu H; Tan D; Zhang H
Int J Mol Sci; 2014 May; 15(6):9718-34. PubMed ID: 24886814
[TBL] [Abstract][Full Text] [Related]
4. Unusual Multinucleated Giant Cell Reaction in a Tongue Squamous Cell Carcinoma: Histopathological and Immunohistochemical Features.
Sánchez-Romero C; Carlos R; Dantas Soares C; Paes de Almeida O
Head Neck Pathol; 2018 Dec; 12(4):580-586. PubMed ID: 29427031
[TBL] [Abstract][Full Text] [Related]
5. Absence of multinucleated giant cell reaction as an indicator of tumor progression in oral tongue squamous cell carcinoma.
de Medeiros VA; de Pontes Santos HB; de Brito Monteiro BV; da Paz AR; Alves PM; Nonaka CFW
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3123-3130. PubMed ID: 34689239
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
7. Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction.
Milde R; Ritter J; Tennent GA; Loesch A; Martinez FO; Gordon S; Pepys MB; Verschoor A; Helming L
Cell Rep; 2015 Dec; 13(9):1937-48. PubMed ID: 26628365
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of SPARC in esophageal squamous cell carcinoma.
Chen Y; Zhang Y; Tan Y; Liu Z
Biochem Biophys Res Commun; 2017 Oct; 492(2):184-191. PubMed ID: 28818666
[TBL] [Abstract][Full Text] [Related]
9. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma.
Guo SJ; Lin DM; Li J; Liu RZ; Zhou CX; Wang DM; Ma WB; Zhang YH; Zhang SR
Dis Esophagus; 2007; 20(2):107-16. PubMed ID: 17439593
[TBL] [Abstract][Full Text] [Related]
12. Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Han U; Can OI; Han S; Kayhan B; Onal BU
Dis Esophagus; 2007; 20(5):379-85. PubMed ID: 17760650
[TBL] [Abstract][Full Text] [Related]
13. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
14. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.
Liu YP; Ma L; Wang SJ; Chen YN; Wu GX; Han M; Wang XL
Eur J Surg Oncol; 2010 Feb; 36(2):155-9. PubMed ID: 19854606
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Sato H; Daiko H; Nakanishi Y
Eur J Cardiothorac Surg; 2001 Jun; 19(6):887-93. PubMed ID: 11404147
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
20. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
